Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on MXX014 31. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN112961153B details a safe, high-yield route for moxifloxacin impurities, offering cost reduction in API manufacturing and enhanced supply chain reliability.